switch semaglutide to tirzepatide Switching Switching from Semaglutide to Tirzepatide

Description

Some of these Mounjaro patients even experienced severe and life-threatening gastrointestinal complications that required surgery and other kinds of emergency treatment

It is available under two brand names and indications: Zepbound Weight loss for people with obesity (BMI of 30 or higher) or Weight loss for people with overweight (BMI of 27 or higher) who have a weight-related health condition like high blood pressure, high cholesterol, type 2 diabetes, obstructive sleep apnea, or cardiovascular disease Mounjaro Blood sugar control for people with type 2 diabetes Tirzepatide is a dual-agonist GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) medication

Self-pay pricing will remain unchanged

If you want to explore this, talk to your GP and ask them to refer you to an endocrinologist or obesity medicine specialist who is connected to trial networks